Longitudinal Assessment of Rod Function in Intermediate Age-Related Macular Degeneration With and Without Reticular Pseudodrusen
Investigative Ophthalmology & Visual Science2019Vol. 60(5), pp. 1511–1511
Citations Over TimeTop 10% of 2019 papers
Abstract
A decrease in RRR was detected over 12 months at 12° eccentricity in the AMD group. Evaluating changes in rod function requires testing at multiple locations including the peripheral macula.
Related Papers
- Initial Anatomic and Visual Results in Patients after Intravitreal Ranibizumab Injection for Neovascular Age-Related Macular Degeneration(2009)
- Evolution of macular atrophy in eyes with neovascular age-related macular degeneration treated with anti-VEGF agents compared to fellow dry AMD eyes(2021)
- → Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum](2017)
- Efficacy of intravitreal ranibizumab injections (IVR) without initial loading doses in patients with neovascular age-related macular degeneration (wAMD)(2014)
- Central Choroidal Thickness is Significantly Diminished Following anti-VEGF Treatment for Neovascular Age Related Macular Degeneration(2014)